Past Conference Report, Jdtba Vol: 8 Issue: 2
3rd WORLD BIOMARKERS SUMMIT: PAST CONFERENCE REPORT
Alessandra Rossi
M.Sc. Molecular Biology, Post-Doctoral Scientist, University of Bologna, Bologna, Italy, E-mail: alessandra.rossi10@studio.unibo.it
Keywords: Pharmaceutical
The past conference of Biomarkers i.e.; “Annual Biomarkers Congress” which is slated on September 17-18, 2018 at Osaka, Japan with the theme Biomarkers: a new era of detection and clinical exploration. Few of the organizing committee members of this conference are Nancy Lan Guo (West Virginia University, USA), Thomas Bayne (Director, National University of Health Sciences, USA), Kenji Suzuki (Professor, Illinois Institute of Technology, USA), Daniel W. Chan (Professor, Johns Hopkins University, USA), Sergey Suchkov (Director, Sechenov University, Russia), Yoshinori Murakami (Professor, University Of Tokyo, Japan).
With Immense pleasure, Biomarkers Congress 2018 along with the Organizing Committee Members invites all the participants from all across the globe to attend “Annual Biomarkers Congress” which is slated on September 17-18, 2018 at Osaka, Japan with the theme Biomarkers: a new era of detection and clinical exploration. The key vital goal of Meetings International is to impart science and medicinal research amongst the academic/scholarly community, and industry. Biomarkers in the hands of the clinical inspector offer a powerful and effective approach to understanding the opportunity of diseases with distinct applications in analytic epidemiology, biomarkers and clinical research in disease prevention, detection and disease management. Biomarkers have the possible supplementary to find each susceptible to particular diseases. This conference is a platform that brings and shares collective ideas, knowledge and research survey in biomarkers study. In the recent years, the statistics about cancer biomarkers has expanded a massive potential for upgrade the administration of cancer patients by boost the precision of diagnosis and efficacy of treatment. Recent technological improvement has a license the investigation of many viable biomarkers and recommences interest in advancing new biomarkers. All such developments can be exhibits in this biomarker congress.
World Biomarkers 2018 conference will be organized by Meetings International which is comprised of 3000+ international Events with over 2000+ Conferences, 1200+ Symposiums and Workshops on multiple fields of clinical, medical, Pharmaceutical, Engineering, Science, Technology, and Business.
This is the best opportunity to reach the largest mass of participants from the Biomarkers and its associated areas. Conduct presentations, distribute statistics, meet with current and potential scientists, construct a dashing with new Development of Biomarkers, and receive name identification at this 2-day event. World-renowned speakers, the most recent techniques, evolution, and the recent updates in Biomarkers are hallmarks of this conference.
Target Audience:
Biomarker Research Students and Scientists
Biomarker Researchers
Cancer and other Diseases Researchers
Medical Colleges & Pharmacology Professionals
Biomarker Associations and Societies
Bio pharmacists, Biochemist, and Biotech Professionals
Manufacturing Biomarkers Instruments Companies
Research and Diagnostic Laboratories and Companies
Data Management Companies
Pharmaceutical Companies
Business Entrepreneurs
Annual biomarker conference is the best forecast conference. It is the best way to integrate with industry squint and discover knowledge and resources. This is the best platform to achieve the largest gathering of participants from the biomarkers and genomics community. This is the best platform for them who are well reputed in this field like professors, oncologists, scientists, students, research scholars. To enhance the biomarkers market this global event is perfect for new biomarkers in different applications.
Meetings International warmly invites all the renowned character, Reputed Scientists and Speakers, Industry Professionals, Healthcare and educational Professionals from the Healthcare and Oncology field to share their ideas and methodologies in this global event. This will bring excellent result. It is open to all types of research methodologies both from academic and industry
Description
Biomarkers Congress 2018 aims to provide a unique scientific and technical platform to share the research experiences among the best-available experts and professionals from all over the world. It will include keynote speakers, session speakers, poster presenters who will be presenting their innovative research on the topics such as Biomarker, Biomarkers in medicines, Biomarkers in cancer detection, Biomarkers in drug development, Biomarkers in toxicology, Development of biomarkers, genomics biomarkers, protein biomarkers, diagnostic biomarkers. The important structures of this conference are an opening session; topical sessions with keynote addresses and oral contributions, symposium, poster presentations well-organized workshops and world-class exhibits, panel discussions, interactive sessions, panel discussions, collaborative research opportunities.
The biomarkers market is forecast to reach USD 53.34 Billion by 2021 from USD 27.95 Billion in 2016, developing at a CAGR of 13.8% during the forecast period (2016–2021). Disease diagnostic application remains the key area of application that is expected to reach 6.1 $billion in 2020.But, application of diagnostic biomarkers in forensics and molecular diagnostics is catching up quite significantly. Molecular diagnostics is expected to grow at a CAGR of 17.6% from 2013 to 2020.
Scope
Market by technologies, market by services, and market by diseases are the three categories of the report section in a market of Global Diagnostic Biomarker. These markets are expected to display raised growth in future as biomarkers are providing diagnostic service for complicated disease. As it is non-invasive mechanism it prompts the use of biomarkers than conventional diagnostic applications. This report focuses on key factors impacting the diagnostic biomarker market used in risk analysis, disease diagnosis, molecular diagnostics, drug discovery and development, forensic applications, drug formulation and others. Diagnostic biomarker and its applications in emerging sections of omics, imaging technologies, customized medicine, and bioinformatics are all examined in detail.
Asia-Pacific biomarkers market is separated based on the product, category, application, and disease symptom. Based on product, the market is further sub-separated as consumables, software, and services. Based on the type, the market is separated as welfare biomarkers, efficacy biomarkers, and validation biomarkers. Biomarkers application is again separated as diagnostics developments, drug discovery & developments, customized medicine, and disease risk analysis. Based on disease symptom, the market is separated as cancer, cardiovascular, neurological, and immunological disorders.
Global Expert Meetings Annual Biomarkers Congress will be organized during September 17-18, 2018, 2018 in Osaka, Japan. Biomarkers Congress 2018 aims to gather eminent scientists, research scholars, and educationists and professionals to express their views on the latest technologies, trends in biomarkers. It centralizes on addressing the constant effort being made by scientist and scholars to improve the existing and inventing novel technologies for future.
Conference Highlights:
• Biomarker
• Clinical Biomarker
• Biomarker Sciences
• Biomarker Discovery
• Biomarker Operations
• Translational research/Sciences
• Companion Diagnostics
• Precision medicine
• Personalized medicine
• Biomarker research
• Biological Sciences
• Biomarkers in oncology
• Immunology Biomarkes
• Molecular Biomarkers
• Biomarkers and Drug Discovery
• Case Reports
• Biomarkers and Next-Generation Sequencing
• Biomarker Identification Technique
CONFERENCE GLIMPSES
-
3rd World Biomarkers Summit
Paris, France
